Correction: 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.

Journal

Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965

Informations de publication

Date de publication:
2022
Historique:
entrez: 9 3 2022
pubmed: 10 3 2022
medline: 10 3 2022
Statut: epublish

Résumé

[This corrects the article DOI: 10.18632/oncotarget.24720.].

Identifiants

DOI: 10.18632/oncotarget.28199 PMID: 35261722 PMC: PMC8896966
pubmed: 35261722
doi: 10.18632/oncotarget.28199
pii: 28199
pmc: PMC8896966
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

331

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright: © 2022 Nagaprashantha et al.

Auteurs

Lokesh Dalasanur Nagaprashantha (LD)

Department of Medical Oncology, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA.

Jyotsana Singhal (J)

Department of Medical Oncology, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA.
Department of Molecular Medicine, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA.

Hongzhi Li (H)

Department of Computational Therapeutics, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA.

Charles Warden (C)

Department of Genomic Core, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA.

Xueli Liu (X)

Department of Information Sciences & Biostatistics, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA.

David Horne (D)

Department of Molecular Medicine, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA.

Sanjay Awasthi (S)

Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.

Ravi Salgia (R)

Department of Medical Oncology, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA.

Sharad S Singhal (SS)

Department of Medical Oncology, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA.

Classifications MeSH